SHOULDER INNOVATIONS, INC. Capital Expenditures Incurred but Not yet Paid
SHOULDER INNOVATIONS, INC. (SI) reported Capital Expenditures Incurred but Not yet Paid of $379.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$990.00K, a 656.18% decline year-over-year.
- SHOULDER INNOVATIONS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.37M, a 420.53% increase year-over-year.
- SHOULDER INNOVATIONS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $346.00K.
- SHOULDER INNOVATIONS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $313.00K, a 42.46% decline year-over-year.
- SHOULDER INNOVATIONS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $1.10M, a 141.76% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $455.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$990.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $379.00K 10-Q · filed 2026-08-06 | $725.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.37M 10-Q · filed 2026-05-13 | $1.72M derived: sum of 2 quarters · filed 2026-05-13 | $2.03M derived: sum of 3 quarters · filed 2026-05-13 | $2.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $659.00K derived: sum of 2 quarters · filed 2026-03-10 | $837.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.10M 10-K · filed 2026-03-10 |
| 2025-09-30 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $491.00K derived: sum of 2 quarters · filed 2026-08-06 | $754.00K 10-Q · filed 2025-11-12 | $530.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $441.00K 10-Q · filed 2026-08-06 | $217.00K derived: sum of 3 quarters · filed 2026-08-06 | $761.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $263.00K 10-Q · filed 2026-05-13 | $39.00K derived: sum of 2 quarters · filed 2026-05-13 | $583.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $320.00K derived: sum of 2 quarters · filed 2026-03-10 | $455.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $679.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $135.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |